A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease
暂无分享,去创建一个
G. Raghu | M. Scholand | C. Spino | K. Flaherty | J. Lasky | B. Gooptu | L. Spencer | I. Glaspole | I. Rosas | R. Maurer | D. Chambers | P. Dellaripa | M. Perrella | I. Forrest | R. Vassallo | L. Troy | H. Goldberg | J. Solomon | N. Chaudhuri | S. Danoff | D. Lynch | F. Woodhead | S. Hurwitz | P. G. Cox | H. Adamali | M. Gibbons | J. Golden | M. Kolb | TRAIL1 Investigators